Live feed
Filing
SC 13G/A
SC 13G/A0001193125-22-219685·Frazier Life Sciences Public Fund, L.P.
Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2022-08-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-219685
- Form type
- SC 13G/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Aug 12, 2022
- Reporting period
- Aug 02, 2022
- Description
- Schedule 13G beneficial ownership